Jean Trédaniel
Hôpital Paris Saint-Joseph · 231 works · 5,538 citations · h-index 36
Top works
- Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
- Multicenter Case-Control Study of Exposure to Environmental Tobacco Smoke and Lung Cancer in Europe
- Tobacco smoking and gastric cancer: Review and meta-analysis
- Serum p53 antibodies as early markers of lung cancer
- Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface.
- Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002
- Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein
- Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis.
- Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC)
- Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study
- Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer
- Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence
- Prolonged Survival After High-Dose Rate Endobronchial Radiation for Malignant Airway Obstruction
- From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF)
- Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial
- Exposure to environmental tobacco smoke and adult non-neoplastic respiratory diseases
- Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies
- Misclassification of smoking status among women in relation to exposure to environmental tobacco smoke
- Exposure to environmental tobacco smoke and risk of lung cancer: the epidemiological evidence
- Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment.